BIOLOGICAL · Unmapped registry intervention
Recombinant Herpes Zoster Vaccine (RZV)
Find medicine records ·
Find other trials using this name
Clinical trial
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
NCT05879419
Drugs and interventions used in this trial
6 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
MTX Discontinuation
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
MMF Discontinuation
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
MTX maintain
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
MMF maintain
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedRecombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Spondyloarthritisverified · MONDO: spondyloarthropathy
Sjogren's Syndromecandidate · MONDO: Sjogren syndrome
Systemic Sclerosisverified · MONDO: systemic sclerosis
Behçet Diseaseverified · MONDO: Behcet disease
Interventions
Recombinant Herpes Zoster Vaccine (RZV)BIOLOGICAL
MTX DiscontinuationOTHER
MMF DiscontinuationOTHER
PlaceboOTHER
MTX maintainOTHER
MMF maintainOTHER
Sponsors & collaborators
University of Sao Paulo General Hospitallead sponsor
GlaxoSmithKlinecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05879419 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.